AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 73 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,510 | -2.1% | 47,000 | 0.0% | 0.05% | +10.2% |
| Q2 2023 | $111,860 | +35.1% | 47,000 | +4.4% | 0.05% | +16.7% |
| Q1 2023 | $82,800 | +3.1% | 45,000 | +6.5% | 0.04% | -8.7% |
| Q4 2022 | $80,275 | -13.7% | 42,250 | -3.1% | 0.05% | -19.3% |
| Q3 2022 | $93,000 | -13.9% | 43,600 | +14.4% | 0.06% | -12.3% |
| Q2 2022 | $108,000 | -18.2% | 38,100 | +20.4% | 0.06% | +4.8% |
| Q1 2022 | $132,000 | +10.9% | 31,650 | +37.9% | 0.06% | +26.5% |
| Q4 2021 | $119,000 | – | 22,950 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |